18F-FET PET prior to recurrent high-grade glioma re-irradiation-additional prognostic value of dynamic time-to-peak analysis and early static summation images?

about

Feasibility and robustness of dynamic F-FET PET based tracer kinetic models applied to patients with recurrent high-grade glioma prior to carbon ion irradiation

P2860

Q57041888-9078B0A6-46EE-4F51-90EC-2EB6EA8EAAA2

P2860

18F-FET PET prior to recurrent high-grade glioma re-irradiation-additional prognostic value of dynamic time-to-peak analysis and early static summation images?

Item

http://www.wikidata.org/entity/Q38403271

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

18F-FET PET prior to recurrent ...... early static summation images?

@en

type

Item

label

18F-FET PET prior to recurrent ...... early static summation images?

@en

prefLabel

18F-FET PET prior to recurrent ...... early static summation images?

@en

P1476

18F-FET PET prior to recurrent ...... early static summation images?

@en

P2093

Claus Belka

http://www.w3.org/2001/XMLSchema#string

Daniel F Fleischmann

http://www.w3.org/2001/XMLSchema#string

Marcus Unterrainer

http://www.w3.org/2001/XMLSchema#string

Maximilian Niyazi

http://www.w3.org/2001/XMLSchema#string

Nathalie L Albert

http://www.w3.org/2001/XMLSchema#string

Peter Bartenstein

http://www.w3.org/2001/XMLSchema#string

P2860

MGMT gene silencing and benefit from temozolomide in glioblastoma.

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

[18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma.

PET imaging for brain tumor diagnostics.

Patterns of failure for glioblastoma multiforme following limited-margin radiation and concurrent temozolomide.

Treatment response evaluation using 18F-FDOPA PET in patients with recurrent malignant glioma on bevacizumab therapy

Re-irradiation of recurrent glioblastoma multiforme using 11C-methionine PET/CT/MRI image fusion for hypofractionated stereotactic radiotherapy by intensity modulated radiation therapy.

Hypervascular tumor volume estimated by comparison to a large-scale cerebral blood volume radiographic atlas predicts survival in recurrent glioblastoma treated with bevacizumab.

3'-deoxy-3'-18F-fluorothymidine PET and MRI for early survival predictions in patients with recurrent malignant glioma treated with bevacizumab

P2888

s11060-016-2366-8

P304

277-286

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11060-016-2366-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

132

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1053784054

http://www.w3.org/2001/XMLSchema#string

P698

28102485

http://www.w3.org/2001/XMLSchema#string

18F-FET PET prior to recurrent high-grade glioma re-irradiation-additional prognostic value of dynamic time-to-peak analysis and early static summation images?

about

P2860

P2860

18F-FET PET prior to recurrent high-grade glioma re-irradiation-additional prognostic value of dynamic time-to-peak analysis and early static summation images?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698